miR-148a might modulate fat deposition by targeting MAPKAPK5, MAPK3, and MAP2K2, and miR-148 has been shown to affect obesity and modulates adipocyte differentiation [40, 41]. This evidence concerns the gene MAPK3 and obesity disorder.